Relationships between reduced heart rate variability and pre-clinical cardiovascular disease in patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 106, Issue 1, 2014, Pages 110-117

  Cardoso, Claudia RL ^a   Moraes, Raphael AM ^a   Leite, Nathalie C ^a   Salles, Gil F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Aortic stiffness; Carotid atherosclerosis; Heart rate variability; Left ventricular hypertrophy; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ALBUMINURIA; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR PARAMETERS; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC MICROANGIOPATHY; DISEASE DURATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FITNESS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RATE; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCENTAGE FOR ADJACENT RR INTERVALS THAT VARIED BY >50 MS; PULSE WAVE; ROOT MEAN SQUARE FOR DIFFERENCES BETWEEN ADJACENT RR INTERVALS; STANDARD DEVIATION OF ALL NORMAL RR INTERVALS; STANDARD DEVIATION OF THE AVERAGED NORMAL RR INTERVALS FOR ALL 5 MIN SEGMENTS; AGED; ARTERIAL WALL THICKNESS; CAROTID ARTERY DISEASE; COMPLICATION; DIABETIC CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84908023718     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.07.005     Document Type: Article

References (31)

1. Ziegler D., Gries F.A., Mühlen H., Rathmann W., Spüler M., Lessmann F. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers The Diacan Multicenter Study Group. Diabet Med 1993, 19:143-151.
2. Voulgari C., Psallas M., Kokkinos A., Argiana V., Katsilambros N., Tentolouris N. The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes. J Diabetes Complicat 2011, 25:159-167.
3. Borgognoni L., Picciarella A., Di Stefano A., Fontana V., Russo A., Pascucci M., et al. Correlation between glycemic trends assessed by 24h continuous monitoring and autonomic activity in patients with recent onset type 2 diabetes. Diabetes Res Clin Pract 2013, 100:e14-e16.
4. Charles M., Fleischer J., Witte D.R., Ejskjaer N., Borch-Johnsen K., Lauritzen T., et al. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. Diabetologia 2013, 56:101-108.
5. Tesfaye S., Chaturvedi N., Eaton S.E., Ward J.D., Manes C., Ionescu-Tirgoviste C., et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005, 352:341-350.
6. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 2010, 33:434-441.
7. May O., Arildsen H. Long-term predictive power of simple function tests for cardiovascular autonomic neuropathy in diabetes: a population-based study. Acta Diabetol 2011, 48:311-316.
8. Liao D., Carnethon M., Evans G.W., Cascio W.E., Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes 2002, 51:3524-3531.
9. Gottsäter A., Ahlgren A.R., Taimour S., Sundkvist G. Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin Auton Res 2006, 16:228-234.
10. Jensen-Urstad K., Reichard P., Jensen-Urstad M. Decreased heart rate variability in patients with type 1 diabetes mellitus is related to arterial wall stiffness. J Intern Med 1999, 245:57-61.
11. Nishimura M., Hashimoto T., Kobayashi H., Fukuda T., Okino K., Yamamoto N., et al. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transplant 2004, 19:2532-2538.
12. Cardoso C.R., Leite N.C., Freitas L., Dias S.B., Muxfeld E.S., Salles G.F. Pattern of 24-h ambulatory blood pressure monitoring in type 2 diabetic patients with cardiovascular dysautonomy. Hypertens Res 2008, 31:865-872.
13. Cardoso C.R., Ferreira M.T., Leite N.C., Barros P.N., Conte P.H., Salles G.F. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 2009, 205:472-476.
14. Asmar R., Benetos A., Topouchian J., Laurent P., Pannier B., Brisac A.M., et al. Assessment of arterial distensibility by automatic pulse wave velocity: validation and clinical application studies. Hypertension 1995, 26:485-490.
15. Van Bortel L.M., Laurent S., Boutouyrie P., Chowienczyk P., Cruickshank J.K., De Backer T., et al. European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012, 30:445-448.
16. Cardoso C.R., Marques C.E., Leite N.C., Salles G.F. Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients. J Hypertens 2012, 30:940-947.
17. Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., et al. American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008, 21:93-111.
18. Jeng J.S., Chung M.Y., Yip P.K., Hwang B.S., Chang Y.C. Extracranial carotid atherosclerosis and vascular risk factors in different types of ischemic stroke in Taiwan. Stroke 1994, 25:1989-1993.
19. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
20. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93:1043-1065.
21. Crawford M.H., Bernstein S.J., Deedwania P.C., DiMarco J.P., Ferrick K.J., Garson A., et al. ACC/AHA guidelines for ambulatory electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol 1999, 34:912-948.
22. Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Böhm M., et al. 2013 ESH/ESC guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013, 31:1281-1357.
23. Cardoso C.R., Ferreira M.T., Leite N.C., Salles G.F. Prognostic impact of aortic stiffness in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. Diabetes Care 2013, 36:3772-3778.
24. Mogensen U.M., Jensen T., Køber L., Kelbæk H., Mathiesen A.S., Dixen U., et al. Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes 2012, 61:1822-1830.
25. Liatis S., Alexiadou K., Tsiakou A., Makrilakis K., Katsilambros N., Tentolouris N. Cardiac autonomic function correlates with arterial stiffness in the early stage of type 1 diabetes. Exp Diabetes Res 2011, 2011:957901.
26. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., Golden S.H. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141:421-431.
27. Young L.H., Wackers F.J., Chyun D.A., Davey J.A., Barrett E.J., Taillefer R., et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. J Am Med Assoc 2009, 301:1547-1555.
28. Schlaich M.P., Kaye D.M., Lambert E., Sommerville M., Socratous F., Esler M.D. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003, 108:560-565.
29. Gambardella S., Frontoni S., Spallone V., Maiello M.R., Civetta E., Lanza G., et al. Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens 1993, 16:97-102.
30. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393.
31. Pagkalos M., Koutlianos N., Kouidi E., Pagkalos E., Mandroukas K., Deligiannis A. Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy. Br J Sports Med 2008, 42:47-54.